{name}
{subtitle}
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~54 mi. (Hengelo, Netherlands, +226 more cities)
facility
Ziekenhuisgroep Twente ( Site 0469)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~67 mi. (Leeuwarden, Netherlands, +192 more cities)
facility
Medische Centrum Leeuwarden
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~81 mi. (Oldenburg, Germany, +145 more cities)
facility
Pius Hospital Oldenburg ( Site 1202)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types